Literature DB >> 409749

A quantitative evaluation of rheumatoid arthritic activity with Tc-99m HEDP.

H M Park, S A Terman, A S Ridolfo, H N Wellman.   

Abstract

In an attempt to develop a quantitative method of evaluating rheumatoid arthritic activity, Tc-99m HEDP joint uptake values and joint-to-bone ratios were studied in ten adult rheumatoid arthritic patients and 17 nonarthritic patients. A joint-to-bone activity ratio of 1.8 at the fourth hour after injection (RA Index) discriminated clinically active rheumatoid arthritic joints from control joints with 95% accuracy. Serial studies on five patients during drug trial demonstrated a positive correlation between RA Index and the clinical manifestations of rheumatoid arthritic activity. The RA Index may be a useful quantitative parameter for evaluation of rheumatoid arthritic activity following therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 409749

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Measurement of joint inflammation in rheumatoid arthritis with indium-111 chloride.

Authors:  R H Shmerling; J A Parker; W D Johns; D E Trentham
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

2.  Metabolic activity of erosions in rheumatoid arthritis.

Authors:  P Pitt; H Berry; M Clarke; H Foley; J Barratt; V Parsons
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

3.  Scintimetric assessment of synovitis activity during treatment with disease modifying antirheumatic drugs.

Authors:  N Olsen; P Halberg; O Halskov; M W Bentzon
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

Review 4.  Investigation of joint disease.

Authors:  M V Merrick
Journal:  Eur J Nucl Med       Date:  1992

5.  Reappraisal of bone scintigraphy as a new tool for the evaluation of disease activity in patients with rheumatoid arthritis.

Authors:  Sang Jin Lee; Chae Moon Hong; Il Cho; Byeong-Cheol Ahn; Jung Su Eun; Na Ri Kim; Jong Whan Kang; Young Mo Kang
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.